Abstract
5'-[2-(2-Nitrophenyl)-2-methylpropionyl]-2'-deoxy-5-fluorouridine was synthesized as a potential bioreductively activated prodrug of 5-fluoro-2'-deoxyuridine (FUDR). The target compound was stable in both phosphate buffer and human serum and was found to release quickly the parent drug FUDR in quantitative yield upon mild chemical reduction.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, Non-P.H.S.
MeSH terms
-
Biological Availability
-
Biotransformation
-
Drug Stability
-
Floxuridine / analogs & derivatives*
-
Floxuridine / chemical synthesis
-
Floxuridine / chemistry
-
Floxuridine / pharmacokinetics*
-
Humans
-
Oxidation-Reduction
-
Prodrugs / pharmacokinetics*
Substances
-
5'-(2-(2-Nitrophenyl)-2-methylpropionyl)-2'-deoxy-5-fluorouridine
-
Prodrugs
-
Floxuridine